Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker

Europace

Volumn 15, Issue 1, 2013, Pages 71-76

  Schuchert, Andreas ^a   Muto, Carmine ^b   Maounis, Themistoklis ^c   Frank, Robert ^d   Boulogne, Eric ^e   Polauck, Alexander ^f   Padeletti, Luigi ^g  

^a Friedrich Ebert Krankenhaus   (Germany)

^b Ospedale Loreto Mare   (Italy)

^c ONASSIS CARDIAC SURGERY CENTER   (Greece)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e St Jude Medical   (Belgium)

^f St Jude Medical   (Germany)

^g UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cardiac device infection; Cardiac resynchronization therapy; Defibrillator lead; Implantable cardioverter defibrillator; Lead complication; Pacing lead

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; DEVICE INFECTION; DEVICE THERAPY; FEMALE; FOLLOW UP; HEART FAILURE; HEART PACING; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTED HEART PACEMAKER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICIAN; PRIORITY JOURNAL;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; ELECTRODES, IMPLANTED; EQUIPMENT FAILURE; EUROPE; FEMALE; FOLLOW-UP STUDIES; FOREIGN-BODY MIGRATION; HEART FAILURE; HUMANS; INCIDENCE; MALE; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; SINGLE-BLIND METHOD; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84871217968     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus247     Document Type: Article

References (21)

1. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 2010;12:1526-36
2. Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation 2007;115:204-12 (Pubitemid 46105719)
3. Ermis C, Benditt DG. Cardiac resynchronization pacing without defibrillator capability: Is this a viable optioñ Europace 2006;8:499-501 (Pubitemid 43985487)
4. Leclercq C, Mabo C, Daubert JC. Cardiac resynchronization therapy: Which device to implant? Arch Cardiovasc Dis 2008;101:55-60 (Pubitemid 351462759)
5. Daubert JC, Leclercq C, Mabo P. Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator. Europace 2009;11(Suppl 5):v87-92
6. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83 (Pubitemid 34984635)
7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37 (Pubitemid 40110811)
8. Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R et al. Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial. Am Heart J 2008;156:520-6
9. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. New Engl J Med 2005;352:1539-49 (Pubitemid 40517094)
10. Lam SK, Owen A. Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials. BMJ 2007;335:925-35
11. Auricchio A, Metra M, Gasparini M, Lamp B, Klersy C, Curnis A et al. Multicenter Longitudinal Observational Study (MILOS) Group: Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy. Am J Cardiol 2007;99:232-8 (Pubitemid 46084859)
12. Stabile G, Solimene F, Bertaglia E, La Rocca V, Accogli M, Scaccia A et al. Longterm outcomes of CRT-PM versus CRT-D recipients. Pacing Clin Electrophysiol 2009;32:S141-5
13. Bai R, Di Biase L, Elayi C, Ching CK, Barrett C, Philipps K et al. Mortality of heart failure patients after cardiac resynchronization therapy: Identification of predictors. J Cardiovasc Electrophysiol 2008;19:1259-65
14. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P et al. Investigators of the Ontario ICD database. Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol 2010;55:774-82
15. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S et al. Resynchronization-defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-95
16. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A et al. The European cardiac resynchronization therapy survey. Eur Heart J 2009;30:2450-60
17. Cabell C, Heidenreich P, Chu V, Moore CM, Stryjewski ME, Corey GR et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004;147:582-6
18. Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Menon SM et al. Device-related infection among patients with pacemakers and implantable defibrillators: Incidence, risk factors, and consequences. J Cardiovasc Electrophysiol 2010;21:786-90
19. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N et al. PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation 2007; 116:1349-55 (Pubitemid 47417560)
20. Romeyer-Bouchard C, Da Costa A, Dauphinot V, Messier M, Bisch L, Samuel B et al. Prevalence and risk factors related to infections of cardiac resynchronization therapy devices. Eur Heart J 2010;31:203-10
21. Johansen JB, Jørgensen OD, Møller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: Infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011;32:991-8